Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma

被引：0
|
作者：
Driver, Brandon
Miller, Ross A.
Deavers, Michael
Tacha, David
Bernicker, Eric
Cagle, Philip T.
机构：
[1] Houston Methodist Hosp, Houston, TX USA
[2] Biocare Med LLC, Concord, CA USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1913
引用
收藏
页码：475A / 475A
页数：1
相关论文
共 50 条
  • [31] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
    Babayeva, Sabina
    Dyatlov, Artem
    Pallavi, Ranjita
    Fanucchi, Michael
    Puccio, Carmelo
    Lafaro, Rocco
    Shakil, Fouzia
    Fallon, John T.
    Zhong, Minghao
    LABORATORY INVESTIGATION, 2016, 96 : 467A - 467A
  • [32] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Neelima Vidula
    Christina Yau
    Hope S. Rugo
    Breast Cancer Research and Treatment, 2021, 187 : 387 - 395
  • [33] The prevalence of programmed death ligand-1 (PD-L1) expression in non-small cell lung cancer in an unselected, consecutive population
    Skov, Birgit Guldhammer
    Rorvig, Sara Bird
    Jensen, Thomas Hartvig Lindkaer
    Skov, Torsten
    MODERN PATHOLOGY, 2020, 33 (01) : 109 - 117
  • [34] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
    Maureen L. Drakes
    Swati Mehrotra
    Monica Aldulescu
    Ronald K. Potkul
    Yueying Liu
    Anne Grisoli
    Cara Joyce
    Timothy E. O’Brien
    M. Sharon Stack
    Patrick J. Stiff
    Journal of Ovarian Research, 11
  • [35] Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis
    Babayeva, Sabina
    Dyatlov, Arteni
    Pallavi, Ranjita
    Fanucchi, Michael
    Puccio, Carmelo
    Lafaro, Rocco
    Shakil, Fouzia
    Fallon, John T.
    Zhong, Minghao
    MODERN PATHOLOGY, 2016, 29 : 467A - 467A
  • [36] Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer
    Vidula, Neelima
    Yau, Christina
    Rugo, Hope S.
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (02) : 387 - 395
  • [37] Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand-1 (PD-L1) in ovarian cancer
    Drakes, Maureen L.
    Mehrotra, Swati
    Aldulescu, Monica
    Potkul, Ronald K.
    Liu, Yueying
    Grisoli, Anne
    Joyce, Cara
    O'Brien, Timothy E.
    Stack, M. Sharon
    Stiff, Patrick J.
    JOURNAL OF OVARIAN RESEARCH, 2018, 11
  • [38] Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer
    Jove, Maria
    Vilarino, Noelia
    Nadal, Ernest
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S364 - S368
  • [39] Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
    Darb-Esfahani, Silvia
    Kunze, Catarina Alisa
    Kulbe, Hagen
    Sehouli, Jalid
    Wienert, Stephan
    Lindner, Judith
    Budczies, Jan
    Bockmayr, Michael
    Dietel, Manfred
    Denkert, Carsten
    Braicu, Ioana
    Joehrens, Korinna
    ONCOTARGET, 2016, 7 (02) : 1486 - 1499
  • [40] Programmed Cell Death Ligand-1 (PD-L1) Expression in Gastrointestinal Stromal Tumors Correlates Significantly with Presence of Tumor Infiltrating Lymphocytes
    Savant, Deepika
    Vitkovski, Taisia
    Thomas, Rebecca
    Rishi, Arvind
    MODERN PATHOLOGY, 2017, 30 : 199A - 199A
12345